Indication
Cystinuria
Cystinuria is an inherited metabolic disorder characterized by defective transepithelial transport of cystine and other dibasic amino acids—specifically ornithine, lysine, and arginine—across the proximal renal tubule and the small intestine. Read more about Cystinuria
24 drugs 21 manufacturers
Drugs that treat it
Common Cystinuria therapies.
PENICILLAMINE
PENICILLAMINE
VENXXIVA (tiopronin)
TIOPRONIN
DEPEN (penicillamine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCystinuria is an inherited metabolic disorder characterized by defective transepithelial transport of cystine and other dibasic amino acids—specifically ornithine, lysine, and arginine—across the proximal renal tubule and the small intestine.
Driven by pathogenic variants in the *SLC3A1* or *SLC7A9* genes, the impaired reabsorption leads to high urinary concentrations of cystine.
Because cystine has poor solubility in normal acidic urine, it precipitates into crystals and forms recurrent calculi within the renal pelvis, ureters, or bladder.
Clinical manifestations typically begin in childhood or early adulthood and commonly include renal colic, hematuria, recurrent urinary tract infections, and potential urinary tract obstruction that may lead to progressive chronic kidney disease.
- medlineplus.gov
Cystinuria is an inherited metabolic disorder characterized by defective transepithelial transport of cystine and other dibasic amino acids—specifically ornithine, lysine, and arginine—across the proximal renal tubule and the small intestine Driven by pathogenic variants in the *SLC3A1* or *SLC7A9* genes, the impaired reabsorption leads to high urinary concentrations of cystine Because cystine has poor solubility in normal acidic urine, it precipitates into crystals and forms recurrent calculi w...
- nih.gov
Cystinuria is an inherited metabolic disorder characterized by defective transepithelial transport of cystine and other dibasic amino acids—specifically ornithine, lysine, and arginine—across the proximal renal tubule and the small intestine
- nih.gov
Driven by pathogenic variants in the *SLC3A1* or *SLC7A9* genes, the impaired reabsorption leads to high urinary concentrations of cystine Clinical manifestations typically begin in childhood or early adulthood and commonly include renal colic, hematuria, recurrent urinary tract infections, and potential urinary tract obstruction that may lead to progressive chronic kidney disease
- medlineplus.gov
Because cystine has poor solubility in normal acidic urine, it precipitates into crystals and forms recurrent calculi within the renal pelvis, ureters, or bladder
- nih.gov
Clinical manifestations typically begin in childhood or early adulthood and commonly include renal colic, hematuria, recurrent urinary tract infections, and potential urinary tract obstruction that may lead to progressive chronic kidney disease
- nih.gov
Clinical manifestations typically begin in childhood or early adulthood and commonly include renal colic, hematuria, recurrent urinary tract infections, and potential urinary tract obstruction that may lead to progressive chronic kidney disease
Personalize your experience
Follow Cystinuria and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.